Genocea Biosciences Inc GNCAQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 58.78M
- Market Cap
- $58.78
- Volume/Avg
- 22,566 / 9,144
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 74
- Website
- https://www.genocea.com
Valuation
|
Metric
|
GNCAQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GNCAQ
|
|---|---|
Quick Ratio | 1.12 |
Current Ratio | 1.35 |
Interest Coverage | −33.66 |
Quick Ratio
GNCAQ
Profitability
|
Metric
|
GNCAQ
|
|---|---|
Return on Assets (Normalized) | −81.83% |
Return on Equity (Normalized) | −316.05% |
Return on Invested Capital (Normalized) | −148.28% |
Return on Assets
GNCAQ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|@t>kB@? | LOCK|HR^P | $130B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|G$ZVkR% | LOCK|l##> | $82B | |||
| argenx SE ADR
ARGX
| LOCK|>N%!jW& | LOCK|cFD | $62B | |||
| Moderna Inc
MRNA
| LOCK|#MXcnc | LOCK|!Cx | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Y>qx#&j | LOCK|hbg | $40B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|KZc$Fx | LOCK|<X!Y@ | $33B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Y!@>MVt? | LOCK|z@YD? | $26B | |||
| Incyte Corp
INCY
| LOCK|yL?^h<^ | LOCK|#& | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|Yy>@%$ | LOCK|%r> | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|?%j#^vh | LOCK|%$ | $16B |
United States